Quantra Point-of-Care Hemostasis Monitoring
NCT: NCT06328647 · ACTIVE_NOT_RECRUITING
Brief Summary
The investigators will test the hypothesis that utilization of a blood and blood component transfusion algorithm guided by the POC Quantra QPlus System in patients undergoing complex cardiac surgery will reduce RBC, plasma, cryoprecipitate, and platelet transfusion during surgery and the first 12 postoperative hours, compared to standard of care (central laboratory transfusion monitoring at the primary anesthesia provider's discretion).
Frequently Asked Questions
What is Quantra Point-of-Care Hemostasis Monitoring?
Quantra Point-of-Care Hemostasis Monitoring is a clinical trial registered under NCT06328647. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT06328647?
The current status of NCT06328647 (Quantra Point-of-Care Hemostasis Monitoring) is: ACTIVE_NOT_RECRUITING.
When did Quantra Point-of-Care Hemostasis Monitoring start?
Quantra Point-of-Care Hemostasis Monitoring started on 2024-10-03.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.